Roche Advances AI-Derived Drug Target With Partner Recursion
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.
RocheRecursion
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.”
Bloomberg — Roche Advances AI-Derived Drug Target With Partner Recursion